학술논문

Addition of GLP-1 agonist ('Bydureon') and SGLT-2 inhibitor (Dapagliflozin) combination therapy: a case of significant weight loss and improved glycaemic control in a poorly-controlled patient with concurrent depression
Document Type
Journal
Source
DIABETIC MEDICINE; MAR 2017, 34 p102-p103, 2p. Supplement: 1
Subject
Language
English
ISSN
14645491